These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3631686)

  • 1. Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in mice.
    Yancey RJ; Kinney ML; Roberts BJ; Goodenough KR; Hamel JC; Ford CW
    Am J Vet Res; 1987 Jul; 48(7):1050-3. PubMed ID: 3631686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory evaluation of ceftizoxime, a new parenteral cephalosporin.
    Kamimura T; Matsumoto Y; Shigi Y; Nishida M
    Arzneimittelforschung; 1980; 30(10):1662-4. PubMed ID: 6969078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cefazedone with cefazolin and cephalothin in treatment of experimental infections in mice.
    Bergmann R; Wahlig H; Mitsuhashi S
    Arzneimittelforschung; 1979; 29(2a):412-4. PubMed ID: 582716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled hydrolysis of ceftiofur sodium, a broad-spectrum cephalosporin; isolation and identification of hydrolysis products.
    Koshy KT; Cazers AR
    J Pharm Sci; 1997 Mar; 86(3):389-95. PubMed ID: 9050811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro efficacy of N-duopropenide, a recently developed disinfectant containing quaternary ammonium compounds, against selected gram-positive and gram-negative organisms.
    Gutiérrez CB; Alvarez D; Rodríguez-Barbosa JI; Tascón RI; de la Puente VA; Rodríguez-Ferri EF
    Am J Vet Res; 1999 Apr; 60(4):481-4. PubMed ID: 10211693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
    Salmon SA; Watts JL
    Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM; Turnidge JD;
    Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro antibacterial activity of L-105, a new cephalosporin.
    Hikida M; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1986 Nov; 18(5):585-91. PubMed ID: 3492485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in antimicrobial resistance among today's bacterial pathogens.
    Thornsberry C
    Pharmacotherapy; 1995; 15(1 Pt 2):3S-8S. PubMed ID: 7753690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compared sensitivities of 532 bacterial strains to six cephalosporins.
    Courtieu AL; Drugeon H
    Int J Clin Pharmacol Res; 1983; 3(3):195-201. PubMed ID: 6679522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cefamandole: in vitro and in vivo activity].
    Martinetto P; Valtz A; Cavallo GP; Angeretti A
    G Batteriol Virol Immunol; 1979; 72(1-6):44-61. PubMed ID: 553842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies with cefazedone.
    Primavesi CA
    Arzneimittelforschung; 1979; 29(2a):381-4. PubMed ID: 582713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs.
    Pedersen K; Pedersen K; Jensen H; Finster K; Jensen VF; Heuer OE
    J Antimicrob Chemother; 2007 Oct; 60(4):775-81. PubMed ID: 17644533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.